Attached files
| file | filename |
|---|---|
| EX-10.5 - EX-10.5 - ReShape Lifesciences Inc. | rsls-20201231ex105a4eef7.htm |
| 10-K - 10-K - ReShape Lifesciences Inc. | rsls-20201231x10k.htm |
| EX-32.2 - EX-32.2 - ReShape Lifesciences Inc. | rsls-20201231ex322d8c679.htm |
| EX-32.1 - EX-32.1 - ReShape Lifesciences Inc. | rsls-20201231ex321fa6327.htm |
| EX-31.2 - EX-31.2 - ReShape Lifesciences Inc. | rsls-20201231ex312c513e1.htm |
| EX-31.1 - EX-31.1 - ReShape Lifesciences Inc. | rsls-20201231ex311b0ae54.htm |
| EX-21.1 - EX-21.1 - ReShape Lifesciences Inc. | rsls-20201231ex21178ae19.htm |
| EX-10.4 - EX-10.4 - ReShape Lifesciences Inc. | rsls-20201231ex104eed482.htm |
| EX-4.1 - EX-4.1 - ReShape Lifesciences Inc. | rsls-20201231ex418952190.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
ReShape Lifesciences Inc.
San Clemente, California
We hereby consent to the incorporation by reference in Registration Statements on Form S-8 (File Nos. 333-211940, 333-196646, 333-184181, 333-176174, 333-171244, 333-159592, and 333-149662), Form S-3 (File Nos. 333-216600, 333-205353, 333-195855, 333-183313, 333-171944, 333-170503, 333-171052, 333-166011, 333-158516, 333-224066, and 333-225083) and Form S-1 (Nos. 333-215590 and 333-213704), of ReShape Lifesciences Inc. of our report dated March 10, 2021, relating to the consolidated financial statements which appears in this Form 10-K.
/s/ BDO USA, LLP
Costa Mesa, California
March 10, 2021